ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2,2,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
3,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
5,2,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
5,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,1,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
7,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8,3,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
9,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
9,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
10,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
12,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
13,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
14,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
14,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
15,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
16,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
16,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
16,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
18,1,Blood electrolytes decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
18,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
18,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
18,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
18,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
18,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
19,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
19,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
19,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
19,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
19,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
20,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
20,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
20,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
20,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
20,5,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
20,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,8,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
21,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
21,2,Device dislocation,Device issues NEC,Device issues,Prod,N
21,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,4,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
21,5,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
21,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
22,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,Y
23,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
23,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
23,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
25,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
25,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
26,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
26,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
28,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
28,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
28,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
29,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,3,Toe operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
30,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
31,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
32,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
33,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
34,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
34,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
34,3,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
34,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
34,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
35,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
36,1,COVID-19 immunisation,Immunisations,Therapeutic procedures and supportive care NEC,Surg,N
36,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
37,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
37,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
38,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
39,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
40,2,Infusion site urticaria,Infusion site reactions,Administration site reactions,Genrl,N
40,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
41,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
43,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
43,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
44,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
44,2,Heart rate variability increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
45,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
46,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
47,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
48,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
48,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
48,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
49,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
50,1,Sudden onset of sleep,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
51,1,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
51,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
52,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
52,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
53,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
53,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
54,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
54,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,5,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
55,1,Benign lung neoplasm,Respiratory tract and pleural neoplasms benign NEC,Respiratory and mediastinal neoplasms benign (excl mesotheliomas),Neopl,N
55,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
55,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
55,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
55,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
55,7,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
55,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
57,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
57,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
57,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,5,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
57,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
58,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
59,1,Migraine,Migraine headaches,Headaches,Nerv,N
60,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
60,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
61,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
62,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
62,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
63,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
65,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,3,Food refusal,Appetite disorders,Appetite and general nutritional disorders,Metab,N
65,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
66,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
67,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
67,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
68,1,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
68,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
69,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,2,Infusion site discomfort,Infusion site reactions,Administration site reactions,Genrl,N
69,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
69,4,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
70,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
70,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
70,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
70,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
70,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
71,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
72,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
73,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
73,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
74,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
74,2,Cardiac pacemaker evaluation,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
74,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
74,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
74,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
74,6,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
75,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
76,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
76,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
76,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
77,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,2,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
78,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
78,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
78,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
79,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
79,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
79,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
79,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
80,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
81,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
82,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
82,2,Intercepted product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
82,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
83,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
84,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
84,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
85,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
85,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
85,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
86,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
86,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
87,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
88,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
89,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
89,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
89,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
89,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
90,1,Early satiety,Feelings and sensations NEC,General system disorders NEC,Genrl,N
90,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
90,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
91,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
92,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
92,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
93,1,Deafness,Hearing losses,Hearing disorders,Ear,N
94,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
94,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
95,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
95,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
96,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
96,2,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
97,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
98,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
99,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
99,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
100,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
101,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
101,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
102,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
102,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,3,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
103,1,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
103,2,Infusion site infection,Vascular infections,Infections - pathogen unspecified,Infec,N
103,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
103,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
104,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
104,2,Cardiac pacemaker replacement,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
104,3,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
104,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
105,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
106,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
106,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
106,3,Migraine,Migraine headaches,Headaches,Nerv,N
106,4,Ophthalmic migraine,Migraine headaches,Headaches,Nerv,N
106,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
107,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
107,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
108,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
108,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
108,4,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
108,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
109,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
109,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
109,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
109,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
109,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,8,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
110,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
110,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
111,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
112,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
113,1,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
114,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
114,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
114,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
115,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
115,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
116,1,Headache,Headaches NEC,Headaches,Nerv,N
116,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
117,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
117,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
117,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
118,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
119,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
119,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
120,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
120,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
121,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
122,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
123,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
123,2,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
123,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
123,4,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
123,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
123,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
124,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
125,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
125,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
126,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
126,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
127,1,Alcohol use,Alcohol product use,Lifestyle issues,SocCi,N
127,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
127,3,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
128,1,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
129,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
129,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
129,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
130,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
131,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
131,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
131,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
132,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
132,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
133,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
134,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
134,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
134,3,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
135,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
135,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
135,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
136,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
136,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
137,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
137,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
137,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
138,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
138,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
139,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
140,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
140,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
141,1,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
141,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
141,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
142,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
143,1,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
144,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
144,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
145,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
146,1,Infusion site mass,Infusion site reactions,Administration site reactions,Genrl,N
146,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
146,3,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
147,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
147,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
147,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
148,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
148,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
148,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
148,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
149,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
150,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
151,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
151,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
152,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
153,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
153,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
154,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
155,1,Food refusal,Appetite disorders,Appetite and general nutritional disorders,Metab,Y
156,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
156,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
157,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
158,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
158,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
158,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
158,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
158,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
158,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
160,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
160,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
160,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
161,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
162,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
163,1,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
164,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
164,2,Infusion site discomfort,Infusion site reactions,Administration site reactions,Genrl,N
164,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
165,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
166,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
166,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
166,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
167,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
168,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
168,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
169,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
170,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
171,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
171,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
172,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
172,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
173,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
173,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
174,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
174,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
174,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
175,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
176,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
177,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
178,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
178,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
179,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
179,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
179,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
179,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
180,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
180,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
181,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
181,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
181,3,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
182,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
182,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
183,1,Face injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
183,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
184,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
184,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
185,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
185,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
185,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
185,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
185,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
185,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
185,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
186,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
186,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
187,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
187,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
187,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
187,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
187,5,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
187,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
187,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
187,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
187,9,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
187,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
187,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
187,12,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
187,13,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
187,14,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
188,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
188,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
189,1,Carpal tunnel decompression,Peripheral nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
190,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
190,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
191,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
192,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
192,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
192,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
192,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
193,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
193,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
193,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
194,1,Carpal tunnel decompression,Peripheral nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
194,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
194,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
194,4,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
194,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
194,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
195,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
195,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
196,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
196,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
196,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
196,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
196,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
196,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
196,7,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
196,8,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
196,9,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
196,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
197,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
197,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
197,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
198,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
198,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
199,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
200,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
200,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
200,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
201,1,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
201,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
201,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
201,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
202,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
203,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
203,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
204,1,Carpal tunnel decompression,Peripheral nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
205,1,Biopsy,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
205,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
206,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
206,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
206,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
206,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
206,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
207,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
208,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
208,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
209,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
210,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
211,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
211,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
211,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
211,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
212,1,Intercepted product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
212,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
212,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
212,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
213,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
213,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
214,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
215,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
215,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
216,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
217,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
217,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
217,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
218,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
218,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
219,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
219,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
219,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
220,1,Device dislocation,Device issues NEC,Device issues,Prod,N
220,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
220,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
220,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
221,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
221,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
222,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
223,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
223,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
223,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
223,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
224,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
225,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
226,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
226,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
226,3,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
226,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
226,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
227,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
228,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
228,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
229,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
229,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
229,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
229,4,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
229,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
230,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
231,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
232,1,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
232,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
233,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
234,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
235,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
235,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
235,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
235,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
236,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
237,1,Cataract operation,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
238,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
238,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
238,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
239,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
239,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
239,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
240,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
240,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
241,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
242,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
243,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
243,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
243,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
243,5,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
243,6,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
243,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
244,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
245,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
245,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
245,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
245,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
246,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
246,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
247,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
248,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
248,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
249,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
249,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
249,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
250,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
250,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
251,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
252,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
253,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
253,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
254,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
254,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
254,3,Cardiac amyloidosis,Cardiomyopathies,Myocardial disorders,Card,N
254,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
254,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
254,6,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
254,7,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
254,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
255,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
256,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
257,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
258,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
259,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
260,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
260,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
260,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
260,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
261,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
261,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
261,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
261,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
262,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
262,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
262,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
262,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
263,1,Headache,Headaches NEC,Headaches,Nerv,N
264,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
264,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
264,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
264,4,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
264,5,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
264,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
264,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
264,8,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
265,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
265,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
266,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
266,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
266,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
267,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
268,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
268,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
269,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
269,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
269,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
269,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
269,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
270,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
271,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
272,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
272,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
272,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
272,5,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
273,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
274,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
274,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
275,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
275,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
275,3,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
275,4,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
275,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
276,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
277,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
277,2,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
277,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
278,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
280,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
281,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
281,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
281,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
281,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
282,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
283,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
284,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
285,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
285,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
286,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
286,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
287,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
287,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
288,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
289,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
289,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
289,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
289,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
290,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
290,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
291,1,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
292,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
293,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
293,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
293,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
293,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
293,5,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
294,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
294,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
294,3,Infusion site nodule,Infusion site reactions,Administration site reactions,Genrl,N
294,4,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
294,5,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
295,1,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
295,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
295,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
295,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
296,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
297,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
297,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
297,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
298,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
298,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
299,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
300,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
300,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
301,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
301,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
301,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
302,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
302,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
303,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
304,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
305,1,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
305,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
306,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
306,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
306,3,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
307,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
307,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
308,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
308,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
308,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
308,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
308,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
309,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
309,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
310,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
311,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
311,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
312,1,Migraine,Migraine headaches,Headaches,Nerv,N
313,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
314,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
314,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
314,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
314,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
315,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
316,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
316,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
317,1,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
317,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
319,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
319,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
320,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
320,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
320,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
321,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
321,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
321,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
321,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
322,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
323,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
323,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
323,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
324,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
325,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
326,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
326,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
327,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
328,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
328,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
328,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
328,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
329,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
329,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
330,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
331,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
331,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
332,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
332,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
333,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
334,1,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
334,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
334,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
335,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
335,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
335,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
335,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
335,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
336,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
337,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
338,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
338,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
339,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
339,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
340,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
341,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
341,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
341,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
342,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
342,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
343,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
344,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
344,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
345,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
346,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
347,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
348,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
348,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
348,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
348,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
349,1,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
349,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
349,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
350,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
350,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
350,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
350,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
351,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
351,2,Device issue,Device issues NEC,Device issues,Prod,N
351,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
351,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
352,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
352,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
353,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
354,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
355,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
355,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
356,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
357,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
357,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
358,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
358,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
359,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
359,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
360,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
361,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
362,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
363,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
364,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
364,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
364,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
364,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
365,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
366,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
367,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
368,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
369,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
372,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
373,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
374,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
374,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
375,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
376,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
376,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
377,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
378,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
378,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
379,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
380,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
381,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
381,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
382,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
382,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
383,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
384,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
385,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
386,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
387,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
387,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
388,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
388,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
389,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
